Literature DB >> 17236961

Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.

Raymond Miralbell1, Hansjörg Vees, Joan Lozano, Haleem Khan, Meritxell Mollà, Alberto Hidalgo, Dolors Linero, Michel Rouzaud.   

Abstract

PURPOSE: To assess the role of endorectal magnetic resonance imaging (MRI) in defining local relapse after radical prostatectomy for prostate cancer to help to reassess the clinical target volume (CTV) for adjuvant postprostatectomy radiotherapy. METHODS AND MATERIALS: Sixty patients undergoing an endorectal MRI before salvage radiotherapy were selected. Spatial coordinates of the relapses were assessed using two reference points: the inferior border of the pubic symphysis (point 1) and the urethro-vesical anastomosis (point 2). Every lesion on MRI was delineated on the planning computed tomography and center of mass coordinates were plotted in two separate diagrams (along the x, y, and z axes) with the urethro-vesical anastomosis as the coordinate origin. An "ideal" CTV was constructed, centered at a point defined by the mathematical means of each of the three coordinates with dimensions defined as twice 2 standard deviations in each of the three axes. The dosimetric impact of the new CTV definition was evaluated in six adjuvantly treated patients.
RESULTS: The ideal CTV center of mass was located at coordinates 0 (x), -5 (y), and -3 (z) mm with SDs of 6 (x), 6 (y), and 9 (z) mm, respectively. The CTV size was 24 (x) x 24 (y) x 36 (z) mm. Significant rectal sparing was observed with the new CTV.
CONCLUSIONS: A CTV with an approximately cylindrical shape (approximately 4 x 3 cm) centered 5 mm posterior and 3 mm inferior to the urethro-vesical anastomosis was defined. Such CTV may reduce the irradiation of normal nontarget tissue in the pelvis potentially improving treatment tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17236961     DOI: 10.1016/j.ijrobp.2006.08.079

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Authors:  Michael Sia; Tom Pickles; Gerard Morton; Louis Souhami; Himu Lukka; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

2.  Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges.

Authors:  Richard Choo
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

Review 3.  Imaging of prostate cancer local recurrences: why and how?

Authors:  Olivier Rouvière; Thierry Vitry; Denis Lyonnet
Journal:  Eur Radiol       Date:  2009-11-17       Impact factor: 5.315

4.  The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer.

Authors:  F Alongi; B De Bari; P Franco; P Ciammella; T Chekrine; L Livi; B A Jereczek-Fossa; A R Filippi
Journal:  Radiol Med       Date:  2013-01-28       Impact factor: 3.469

5.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

6.  Radiotherapy after radical prostatectomy: immediate or early delayed?

Authors:  D Bottke; D Bartkowiak; M Schrader; T Wiegel
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

Review 7.  The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.

Authors:  Ashesh B Jani; Stanley L Liauw; Michael J Blend
Journal:  Clin Med Res       Date:  2007-06

8.  Recent advances in magnetic resonance imaging of prostate cancer.

Authors:  Nathan Lawrentschuk; Uri Lindner
Journal:  F1000 Med Rep       Date:  2010-12-08

9.  RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.

Authors:  Damien C Weber; Hui Wang; Luca Cozzi; Giovanna Dipasquale; Haleem G Khan; Osman Ratib; Michel Rouzaud; Hansjoerg Vees; Habib Zaidi; Raymond Miralbell
Journal:  Radiat Oncol       Date:  2009-09-09       Impact factor: 3.481

10.  Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.

Authors:  Hans Christian Rischke; Arnd O Schäfer; Ursula Nestle; Natalja Volegova-Neher; Karl Henne; Matthias R Benz; Wolfgang Schultze-Seemann; Mathias Langer; Anca L Grosu
Journal:  Radiat Oncol       Date:  2012-10-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.